Literature DB >> 8248955

Cerebral glucose metabolism as a predictor of rehabilitation after ischemic stroke.

W D Heiss1, H G Emunds, K Herholz.   

Abstract

BACKGROUND AND
PURPOSE: Permanent neurological deficits after ischemic stroke are primarily determined by the location and size of an infarct, but social recovery and rehabilitation also depend on the functional status of brain tissue outside the infarct. Since neuronal loss and functional deactivation in peri-infarct tissue are reflected as changes in flow and metabolism, measurement of glucose consumption may yield an additional measure of rehabilitative capacity.
METHODS: Seventy-six nondiabetic patients (48 men, 28 women; mean age, 56.7 +/- 14.37 years) with a first unilateral supratentorial ischemic infarct were consecutively enrolled. At stable neurological and clinical condition 9 +/- 7.2 days after the attack, cerebral metabolic rate of glucose (CMRglu) in noninfarcted brain regions was measured by positron emission tomography of fluorodeoxyglucose. Outcome was assessed 21 to 77 (mean, 50.5 +/- 11.7) months after the stroke with a rehabilitation index for daily life activities.
RESULTS: At time of assessment of outcome 16 patients had died (score, 0), 22 were completely recovered (score, 200), and 38 had partially improved (rehabilitation score, 5 to 195). Younger age, absence of arterial hypertension and cardiac disease, but also higher global, ipsilateral, and contralateral CMRglu were significantly related to a better final outcome (P = .001), whereas sex and neurological deficits in the subacute stage after stroke were not related to final outcome. To evaluate the significance of CMRglu further after adjustment for clinical prognostic variables, a multiple regression analysis of the effect of age and CMRglu on rehabilitation score in homogeneous subgroups of partially recovered patients was performed. It revealed a significant positive correlation of CMRglu (P = .016) with recovery in hypertensive subjects, while age was the dominant prognostic factor (P = .07) in patients with normal blood pressure.
CONCLUSIONS: These results demonstrate that outcome after stroke is significantly influenced by several factors incapacitating brain function in addition to the ischemic attack. In addition to age and cardiac disease, hypertension is an important factor leading to widespread arteriopathy with neuronal loss and tissue damage. The significant correlation of CMRglu outside the infarct with functional recovery in hypertensive subjects probably reflects the extent of hypertensive tissue damage and subsequently reduced capacity to compensate for the focal ischemic insult.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8248955     DOI: 10.1161/01.str.24.12.1784

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: relation to clinical outcome.

Authors:  A E Baird; M C Austin; W J McKay; G A Donnan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

2.  2-(4-Methoxyphenyl)Ethyl-2-Acetamido-2-Deoxy-β-D-Pyranoside Exerts a Neuroprotective Effect through Regulation of Energy Homeostasis and O-GlcNAcylation.

Authors:  Hui Xu; Huaxiang Gu; Yanhong Yang; Ergai Cai; Fei Ding; Shu Yu
Journal:  J Mol Neurosci       Date:  2019-06-15       Impact factor: 3.444

Review 3.  [Positron emission tomography in neuroscience. An integrative part of clinical diagnostic methods and experimental research].

Authors:  B Schaller
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

4.  Dynamic FDG PET for assessing early effects of cerebral hypoxia and resuscitation in new-born pigs.

Authors:  Charlotte de Lange; Eirik Malinen; Hong Qu; Kjersti Johnsrud; Arne Skretting; Ola Didrik Saugstad; Berit H Munkeby
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05       Impact factor: 9.236

5.  Chemical exchange-sensitive spin-lock (CESL) MRI of glucose and analogs in brain tumors.

Authors:  Tao Jin; Bistra Iordanova; T Kevin Hitchens; Michel Modo; Ping Wang; Hunter Mehrens; Seong-Gi Kim
Journal:  Magn Reson Med       Date:  2018-03-23       Impact factor: 4.668

6.  Glucose metabolism-weighted imaging with chemical exchange-sensitive MRI of 2-deoxyglucose (2DG) in brain: Sensitivity and biological sources.

Authors:  Tao Jin; Hunter Mehrens; Ping Wang; Seong-Gi Kim
Journal:  Neuroimage       Date:  2016-08-26       Impact factor: 6.556

Review 7.  Feeding the brain and nurturing the mind: Linking nutrition and the gut microbiota to brain development.

Authors:  Manu S Goyal; Siddarth Venkatesh; Jeffrey Milbrandt; Jeffrey I Gordon; Marcus E Raichle
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

Review 8.  Neurobiology of Recovery of Motor Function after Stroke: The Central Nervous System Biomarker Effects of Constraint-Induced Movement Therapy.

Authors:  Auwal Abdullahi; Steven Truijen; Wim Saeys
Journal:  Neural Plast       Date:  2020-06-15       Impact factor: 3.599

9.  Analysis of glucose metabolism by 18F-FDG-PET imaging and glucose transporter expression in a mouse model of intracerebral hemorrhage.

Authors:  Xiaoning Han; Honglei Ren; Ayon Nandi; Xuanjia Fan; Raymond C Koehler
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.